Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
about
Staging lymph node metastases from lung cancer in the mediastinumAdvanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.Predicting lung cancer prior to surgical resection in patients with lung nodulesEvidence based imaging strategies for solitary pulmonary nodule.Positron Emission Tomography (PET) in Oncology68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung CancerDiagnostic usefulness of an amino acid tracer, α-[N-methyl-(11)C]-methylaminoisobutyric acid ( (11)C-MeAIB), in the PET diagnosis of chest malignancies.[(18)F]Fluorodeoxyglucose-positron emission tomography screening for lung cancer: a systematic review and meta-analysis.Imaging of solitary pulmonary nodule-a clinical review68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer.The Pursuit of Noninvasive Diagnosis of Lung Cancer.When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?Fungal diseases mimicking primary lung cancer: radiologic-pathologic correlation.Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.PET/CT used in the evaluation of pulmonary nodules suspicious for lung cancer in regions where infectious lung disease is endemic: to be or not to be?Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules.SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients.Dual-time-point 18F-FDG PET/CT in the diagnosis of solitary pulmonary lesions in a region with endemic granulomatous diseases.F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease-endemic region.Therapeutic surgery without a definitive diagnosis can be an option in selected patients with suspected lung cancer.Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.Mapping Histoplasma capsulatum Exposure, United States
P2860
Q26863443-010F47BC-E5F2-4C15-92CE-2482DFD29B0BQ27025770-0193D806-2BB6-479D-8EF5-E3E406E0894FQ30151881-A72A7319-7DD6-48D2-8772-5BAF0F7FE2F2Q30405995-433F96A4-053B-4A59-B6A5-455EAC2631AFQ30610197-F46F80CA-FC3C-4715-B561-A39F393FE5C7Q33995254-A6681A6C-BEED-44D0-B3DA-6318443B6E74Q34774840-BB481487-BA0D-4DCE-8E81-8BA39897B91EQ36275598-85919A49-5FB9-44FB-BA3F-4261C495338DQ36279031-43FC159A-F650-4F58-A767-D5E040CD8518Q37314320-A5F851CA-7947-4038-A474-41EF697FB276Q37394789-087E11AA-BC7A-496D-8D85-5D84502B412CQ37441366-9DB74DD3-BF34-4BB4-821B-A8457D8EB90AQ37575733-82B72F67-92D5-433A-8C28-16DD1867363BQ37652904-8C797A61-C847-4D96-82E9-EAD5BA88CDE7Q38077707-D10FE48B-7222-4052-B4E6-D2008D50DFBAQ38154638-537B6B5F-CFC8-4EBD-BB8A-385D3EFA5FECQ38253400-DC390D5A-D69F-4E60-8425-85BC457F66F5Q38673721-DFAA6405-A4FB-4A76-B8D9-AAF75E4891DEQ40617319-5220ADE3-FC2A-4A6D-941C-9A40014A053FQ40955173-7601E674-FEA9-4446-B4D1-76867F039DD5Q47284858-74952EAC-A7BA-4D11-96A5-A82D947318CEQ47715056-D75F3B75-5A95-49A3-A64C-0D4294810199Q47825180-195C0730-B308-4F5F-A517-DF3E50782A54Q51749246-AA9A75B1-BF27-4BD5-BE6C-C001A0F3A60FQ52984177-761E17E8-8889-4AFD-9661-EEC2A8780DD3Q52987252-C56D019D-E1D3-4B29-9202-8EA758298735Q53059530-65D19A9B-A108-4107-AEFC-06194BC860A3Q53138445-3B97D155-680B-4546-BE86-6460712CC069Q58794152-376D552F-1DBB-4440-81F4-1056FE092953
P2860
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
@ast
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
@en
type
label
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
@ast
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
@en
prefLabel
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
@ast
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
@en
P2093
P2860
P1476
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.
@en
P2093
Eric L Grogan
Eric S Lambright
Gabriela Andrade
Joe B Putnam
Jonathan C Nesbitt
Pierre P Massion
Ron Walker
Stephen Deppen
Theodore Speroff
P2860
P304
428-32; discussion 433
P356
10.1016/J.ATHORACSUR.2011.02.052
P407
P577
2011-05-18T00:00:00Z